Endpoint
Liver injury / hepatotoxicity incidence
CAT:outcome/hepatotoxicity-incidencereported in risk ratio
How it is measured
Proportion of participants with an adjudicated hepatic injury event, defined by the trial as transaminase or bilirubin elevation above a stated protocol threshold (commonly three or five times the upper limit of normal) with or without symptoms.